Role of the cytomegalovirus (CMV)-antigenemia assay as a predictive and follow-up detection tool for CMV disease in AIDS patients

Microbiology and Immunology

Volumn 43, Issue 10, 1999, Pages 959-965

  Hoshino, Yoshihiko ^a   Nagata, Yoichi ^b   Taguchi, Hitomi ^a   Masunaga, Atsuko ^a   Fujino, Yujiro ^c   Mochizuki, Manabu ^d   Nakamura, Tetsuya ^a   Iwamoto, Aikichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c TOKYO KOSEI NENKIN HOSPITAL   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Antigenemia; HIV; Human cytomegalovirus (CMV); Predictive value

Indexed keywords

VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DISEASE MARKER; FOLLOW UP; HUMAN; IMMUNOASSAY; NONHUMAN; PREDICTION; RELAPSE; RETINITIS;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0032702803     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb03356.x     Document Type: Article

References (21)

1. Berman, S.M., and Kim, R.C. 1994. The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir. Am. J. Med. 95: 415-419.
2. Crumpacker, C.S. 1996. Ganciclovir. N. Engl. J. Med. 335: 721-728.
3. Drew, W.L., Stempien, M.J., and Erlich, K.S. 1997. Management of herpesvirus infections, p. 381-397. In Sande, M.A., and Volberding, P.A. (eds), The medical management of AIDS, 5th ed, W.B. Saunders, Philadelphia.
4. Erice, A., Holm, M.A., Gill, P.C., Henry, S., Dirksen, C.L., Dunn, D.L., Hillam, R.P., and Balfour, H.H., Jr. 1992. Cytomegalovirus antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J. Clin. Microbiol. 30: 2822-2825.
5. Francisci, D., Tosti, A., Baldelli, F., Stagni, G., and Pauluzzi, S. 1997. The pp65 antigenemia test as a predictor of cytomegalovirus-induced end organ disease in patients with AIDS. AIDS 11: 1341-1345.
6. Hoshino, Y., Nagata, Y., Gatanaga, H., Hosono, O., Morimoto, C., Tachikawa, N., Nomura, K., Wakabayashi, T., Oka, S., Nakamura, T., and Iwamoto, A. 1997. CMV retinitis and CMV antigenemia as a clue to impaired adrenocortical function in patients with AIDS. AIDS 11: 1719-1724.
7. Ives, D.V. 1997. Cytomegalovirus disease in AIDS. AIDS 11: 1791-1797.
8. Jacobson, M.A. 1997. Treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. N. Engl. J. Med. 337: 105-114.
9. Jacobson, M.A., Zegans, M., Paven, P.R., O'Donnell, J.J., Sattler, F., Rao, N., Owens, S., and Pollard, R. 1997. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349: 1443-1445.
10. Kurihara, T., Hayashi, J., Matsuoka, T., and Ito, A. 1995. HCMV pp65 antigenemia assay using indirect alkaline phosphatase staining method. Biochem. Res. 16: 125-129.
11. Lane, H.C. 1994. Recent advances in the management of AIDS-related opportunistic infections. Ann. Intern. Med. 120: 945-955.
12. Mastroianni, C.M., Ciardi, M., Folgori, F., Sebastiani, G., Vullo, V., Delia, S., and Sorice, F. 1994. Cytomegalovirus encephalitis in two patients with AIDS receiving ganciclovir for cytomegalovirus retinitis. J. Infect. 29: 331-337.
13. Masur, H., Whitcup, S.M., Cartwright, C., Polis, M., and Nussenblatt, R. 1996. Advances in the management of AIDS-related cytomegalovirus retinitis. Ann. Intern. Med. 125: 126-136.
14. McCutchan, A.J. 1995. Cytomegalovirus infections of the nervous system in patients with AIDS. Clin. Infect. Dis. 20: 747-754.
15. Moore, R.D., and Chaisson, R.E. 1997. Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis. J. Acquir. Immune Defic. Syndr. 16: 15-21.
16. Podzamczer, D., Ferrer, E., Garcia, A., Ramon, J.M., Niubo, J., Santin, M., Rufi, G., Perez, J.L., Martin, R., and Gudiol, F. 1997. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients. Scand. J. Infect. Dis. 29: 223-227.
17. Rose, D.N., and Sacks, H.S. 1997. Cost-effectiveness of cytomegalovirus (CMV) disease prevention in patients with AIDS: oral ganciclovir and CMV polymerase chain reaction testing. AIDS 11: 883-887.
18. Schwarz, T.F., Loeschke, K., Hanus, I., Jager, G., Feiden, W., and Stefani, F.H. 1990. CMV encephalitis during ganciclovir therapy of CMV retinitis. Infection 18: 289-290.
19. Specter, S.A., Mckinley, G.F., Lalezari, J.P., Samo, T., Andruczk, R., Follansbee, S., Sparti, P.D., Havlir, D.V., Simpson, G., Buhles, W., Wong, R., and Stempien, M. 1996. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N. Engl. J. Med. 334: 1491-1497.
20. Van Der Bij, W., Schirm, J., Torensma, R., Van Son, W.J., Tegzess, A.M., and The, T.H. 1988. Comparison between viremia and antigenemia for the detection of cytomegalovirus in blood. J. Clin. Microbiol. 26: 2531-2535.
21. Whitcup, S.M., Fortin, E., Nussenblatt, R.B., Polis, M.A., Muccioli, C., Belfort, R., Jr. 1997. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. JAMA 277: 1519-1520.